Sector revisions Vanda Pharmaceuticals Inc.
Equities
VNDA
US9216591084
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.470 USD | +0.27% |
|
+1.91% | -15.31% |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | 4 | |||||||
| 15 | |||||||
| 18 | |||||||
| 18 | |||||||
| 19 | |||||||
| 25 | |||||||
| 13 | |||||||
| 21 | |||||||
| 17 | |||||||
| 13 | |||||||
| 18 | |||||||
| - | - | - | - | - | 1 | ||
| 14 | |||||||
| 10 | |||||||
| 17 | |||||||
| 15 | |||||||
| 18 | |||||||
| Average | 15 | |||||||
| Weighted average by Cap. | 17 |
- Stock Market
- Equities
- VNDA Stock
- Sector Vanda Pharmaceuticals Inc.
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition